Rights and permissions
About this article
Cite this article
Rivastigmine may be effective in the treatment of patients with Alzheimer's disease who have vascular risk factors. Inpharma Wkly. 1230, 12 (2000). https://doi.org/10.2165/00128413-200012300-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012300-00022